Doxazosin for Benign Prostatic Hyperplasia: Long-term Efficacy and Safety in Hypertensive and Normotensive Patients

Author:

Lepor Herbert1,Kaplan Steven A.1,Klimberg Ira1,Mobley David F.1,Fawzy Ahmed1,Gaffney Michael1,Ice Kathleen1,Dias Norma1

Affiliation:

1. Multicenter Study Group; From the Departments of Urology, New York University and Columbia University, and Pfizer Central Research, New York, New York, Urology Center of Florida, Ocala, Florida, Memorial Hospital, Houston, Texas, and Department of Urology, Louisiana State University Medical Center, New Orleans, Louisiana.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference27 articles.

1. High prevalence of benign prostatic hypertrophy in the community;Garraway;Lancet,1991

2. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men;Garraway;Brit. J. Gen. Pract.,1993

3. Benign Prostatic Hyperplasia: Diagnosis and Treatment. Quick Reference Guide for Clinicians;McConnell,1994

4. Benign prostatic hyperplasia. Current pharmacological treatment;Jonler;Drugs,1994

5. Risk factors for cardiovascular disease: "clustering" in the older hypertensive man;Poulter;Brit. J. Clin. Pract.,1994

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3